My ePortfolio Register   

Gastric cancer biology and aetiology

Please rate this video

Please complete at least one question.

  1. The information in this video was of interest to me Disagree Agree
  2. The information in this video is likely to improve my clinical practice or research Disagree Agree
  3. I would recommend this video to my colleagues Disagree Agree
Thanks for rating
There has been a problem, please refresh and try again.
Published: 20.12.16
Views: 794

Prof Florian Lordick - University Cancer Centre Leipzig, Germany

Prof Lordick speaks with ecancertv at the Immuno-Oncology Hong Kong 2016 meeting about the classifications of gastric cancer, and how they might inform treatment.

He outlines known biomarkers for patient subtyping, and considers when sequential treatment, anti-angiogenic therapy or combination therapies might be best used.

Prof Lordick also introduces the 2019 Gastric Cancer Congress in Prague.

Related videos

follow us

Founding partners

European Cancer Organisation European Institute of Oncology

Founding Charities

Foundazione Umberto Veronesi Fondazione IEO Swiss Bridge

Published by

Cancer Intelligence